AstraZeneca appoints Svexa's Dr Euan Ashley as a Non-Executive Director

We're excited to announce that Svexa's Chairman of the Board Dr Euan Ashley has been appointed as a Non-Executive Director and a member of the Science Committee for leading British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca.

Euan is Associate Dean and Professor of Cardiovascular Medicine and Genetics at Stanford University in California.  His research focuses on genetic mechanisms of cardiovascular health and disease.  In addition to wet bench science, his laboratory leverages artificial intelligence and digital health tools, working with biotechnology and technology partners in Silicon Valley, to advance both translational and clinical research.

Euan has received many awards including recognition from the Obama White House for contributions to personalized medicine and the American Heart Association’s Medal of Honor for precision medicine. The efforts and improvements in clinical precision medicine that his team leads worldwide is a foundational pillar in Svexa's work in precision health and individualized optimization of training and performance.